AHA Meeting Highlights

Vericiguat Did Not Significantly Affect NT-proBNP Level in Chronic Heart Failure With Reduced LVEF

Britt Gambino

November 9, 2015

NT-proBNP levels were not significantly affected by vericiguat, a soluble guanylate cyclase stimulator, in patients with chronic heart failure and reduced LVEF.

AHA Meeting Highlights

3D Reconstruction May Improve Donor Selection for Pediatric Heart Transplants

Haymarket Media

November 9, 2015

Developing 3D technology could help surgeons choose donors for pediatric heart transplants.

AHA Meeting Highlights

Most Women Not Aware They Could Be at Risk for Heart Disease

Haymarket Media

November 9, 2015

A recent survey showed that many women in the United States do not feel personally connected to the risk of heart disease.

Next post in AHA Meeting Highlights

AHA Meeting Highlights

Vericiguat Did Not Significantly Affect NT-proBNP Level in Chronic Heart Failure With Reduced LVEF

3D Reconstruction May Improve Donor Selection for Pediatric Heart Transplants

Most Women Not Aware They Could Be at Risk for Heart Disease

Want to read more?

Nitric Oxide With Prolonged Cardiopulmonary Bypass May Help Prevent Acute Kidney Injury